$ESV 2Q15 Call: Second quarter results were highlighted by good operational safety and financial performance. Earnings from continuing operations excluding costs to refinance debt were $1.18 per share for the second quarter. Our teams have kept their focus on the things that we can control operations, safety and efficiency.
For 2017, $ENDP expects US Generics base business revenue decline to be similar to 2016 or in the low 30% range. Generics segment sales are expected to decline in the high-single to low-double digit range. In US Generics business, $ENDP estimates to realize approx. $75MM in annual net savings and launch at least 20 products in 2017.
$EQIX agreed for the purchase of ICT-Center AG, Zurich's data center operating business in Zurich, Switzerland for less than $5MM. The agreement was signed on Feb. 1, 2017 and the acquisition is expected to close sometime in early April 2017.